KM Research Hub
← 返回论文库
待处理 入排:排除 图源:待检查

Avatrombopag for the treatment of patients with chemotherapy-induced thrombocytopenia: A case series.

Robert Galamaga, Stephanie Johnston, Cassaundra Acosta

Br J Haematol 206(1) 272-278

PMID39434457
PMCIDPMC11739760
DOI10.1111/bjh.19797
发表日期2024-10-22
摘要

摘要

Management of chemotherapy-induced thrombocytopenia (CIT) is challenging, often resulting in chemotherapy treatment delays, dose reduction, and treatment interruption. Randomized trials support the potential efficacy and safety of thrombopoietin receptor agonists in CIT management. A phase III trial of avatrombopag (AVA) demonstrated increased platelet counts (PC) in patients with solid tumours experiencing CIT. To complement those findings, this case series of six patients with solid tumours and CIT is presented. Results from these cases support the clinical benefit of AVA in improving PC and reducing the impact of CIT on tumour treatment, allowing continued therapy without dose reduction or treatment interruption.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。